112 related articles for article (PubMed ID: 9578507)
1. GH dependence and GH withdrawal syndrome in GH treatment of short normal children: evidence from growth and cardiac output.
Lampit M; Lorber A; Vilkas DL; Nave T; Hochberg Z
Eur J Endocrinol; 1998 Apr; 138(4):401-7. PubMed ID: 9578507
[TBL] [Abstract][Full Text] [Related]
2. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
Lampit M; Hochberg Z
J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
[TBL] [Abstract][Full Text] [Related]
3. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
4. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
Kawai N; Kanzaki S; Takano-Watou S; Tada C; Yamanaka Y; Miyata T; Oka M; Seino Y
J Clin Endocrinol Metab; 1999 Jan; 84(1):82-9. PubMed ID: 9920066
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.
Juul A; Skakkebaek NE
J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120
[TBL] [Abstract][Full Text] [Related]
6. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
7. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
9. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
[TBL] [Abstract][Full Text] [Related]
10. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
[TBL] [Abstract][Full Text] [Related]
11. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?
Cianfarani S; Tondinelli T; Spadoni GL; Scirè G; Boemi S; Boscherini B
Clin Endocrinol (Oxf); 2002 Aug; 57(2):161-7. PubMed ID: 12153594
[TBL] [Abstract][Full Text] [Related]
12. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
[TBL] [Abstract][Full Text] [Related]
13. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone treatment of short stature and metabolic dysfunction in juvenile chronic arthritis.
Simon D; Touati G; Prieur AM; Ruiz JC; Czernichow P
Acta Paediatr Suppl; 1999 Feb; 88(428):100-5. PubMed ID: 10102064
[TBL] [Abstract][Full Text] [Related]
15. Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.
Kriström B; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Sep; 82(9):2889-98. PubMed ID: 9284715
[TBL] [Abstract][Full Text] [Related]
16. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
[TBL] [Abstract][Full Text] [Related]
18. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human growth hormone treatment for dilated cardiomyopathy in children.
McElhinney DB; Colan SD; Moran AM; Wypij D; Lin M; Majzoub JA; Crawford EC; Bartlett JM; McGrath EA; Newburger JW
Pediatrics; 2004 Oct; 114(4):e452-8. PubMed ID: 15466071
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
